MedPath

Physiological and systemic effects of activities of daily living in COPD patients.

Conditions
Chronic bronchitis
emphysema
10038716
Registration Number
NL-OMON32002
Lead Sponsor
niversitair Medisch Centrum Sint Radboud
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

COPD GOLD II, III, IV patients

Exclusion Criteria

Long term oxygen therapy, respiratory insufficiency (PaO2 lower than 8.0kPa, PaCO2 higher than 6.3kPa), asthma, exercise limiting disorders, exacerbation in last 6 weeks. Supplementary exclusion criteria for the systemic inflammation part: smoking, oral corticosteroids, chronic inflammatory disorders

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>1. Respiratory physiology<br /><br>Increase in severity of ventilatory impairment during ADL in patients with<br /><br>respectively COPD GOLD stages II, III and IV.<br /><br><br /><br>2. Systemic inflammation<br /><br>Increase in systemic inflammatory markers after ADL in COPD patients.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>-</p><br>
© Copyright 2025. All Rights Reserved by MedPath